Literature DB >> 33992597

Use Chou's 5-steps rule to study how Baicalin suppresses the malignant phenotypes and induces the apoptosis of colorectal cancer cells.

Wei Zhang1, Quanlin Liu2, Linshan Luo1, Jingfeng Song1, Keshun Han3, Ruitao Liu4, Yuesheng Gong4, Xiaoran Guo1.   

Abstract

Baicalin is a traditional Chinese herb purified from the root of Scutellaria baicalensis Georgi. In this study, we further analyzed the molecular mechanism behind the anti-tumor activity of Baicalin in colorectal cancer (CRC). The establishment of circular RNA (circRNA)/microRNA (miRNA)/messenger RNA (mRNA) axis was predicted by bioinformatic databases and verified by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Baicalin dose-dependently reduced the expression of circRNA myosin heavy chain 9 (circMYH9) in CRC cells. Baicalin exposure suppressed the malignant phenotypes of CRC cells, which were largely reversed by the overexpression of circMYH9. CircMYH9 functioned as a molecular sponge for miR-761. CircMYH9 overexpression protected CRC cells from Baicalin-induced injury partly through down-regulating miR-761. MiR-761 interacted with the 3' untranslated region (3' UTR) of hepatoma-derived growth factor (HDGF) mRNA. CircMYH9 up-regulated HDGF expression partly through sponging miR-761 in CRC cells. MiR-761 silencing counteracted the anti-tumor activity of Baicalin partly through up-regulating HDGF in CRC cells. Baicalin suppresses xenograft tumor growth in vivo, and this suppressive effect was partly reversed by the overexpression of circMYH9. In conclusion, Baicalin exhibited an anti-tumor activity in CRC cells partly through down-regulating circMYH9 and HDGF and up-regulating miR-761.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baicalin; Colorectal cancer; HDGF; circMYH9; miR-761

Year:  2021        PMID: 33992597     DOI: 10.1016/j.abb.2021.108919

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

Review 1.  Latest research progress on anticancer effect of baicalin and its aglycone baicalein.

Authors:  Lin Wang; Ting Feng; Zhilian Su; Chao Pi; Yumeng Wei; Ling Zhao
Journal:  Arch Pharm Res       Date:  2022-07-31       Impact factor: 6.010

2.  Recent insights into the biological functions of baicalin.

Authors:  Priscilla Nadalin; Jae Kwang Kim; Tae Won Kim; Sang Un Park
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

Review 3.  Using omics approaches to dissect the therapeutic effects of Chinese herbal medicines on gastrointestinal cancers.

Authors:  Si-Yi Li; Wei-Jia Wang; Qiu-Yue Li; Peng-Hui Yang; Xin-Long Li; Yan Yan; Yong Yuan; Yi-Bin Feng; Ming Hong
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.